Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
Biorealism's comments
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
What is known is the nearest relatives to SARS-CoV-2 are found in Yunnan and Laos. Both areas WIV sampled and they refuse to share their records with WHO or the NIH.
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
https://thebulletin.org/2022/08/nih-to-terminate-ecohealth-a...
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
In 2018, WIV was part of a proposal with EcoHealth Alliance and UNC to add furin cleavage sites into novel SARS-related bat coronaviruses. DARPA declined to fund it. This investigation suggests the work went ahead. Something Nick Patterson suggested often occurs even when funding is declined. WIV had both NIAID and CAS grants to study spillover risk of SARS-related coronaviruses. They were also doing classified work with the PLA from 2017.
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
https://thebulletin.org/2022/08/nih-to-terminate-ecohealth-a...
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
https://news.yahoo.com/raccoon-dogs-did-not-start-covid-19-n...
Biorealism | 2 years ago | on: Inside the Wuhan lab weeks before Covid
They refuse to share their records with WHO or the NIH. That's a crucial caveat when saying there is no evidence they held a precursor. We don't know as they have refused to share their database.
The Times article is interesting as it suggests the work in DEFUSE to add furin cleavage sites went ahead and they passaged the virus in humanized mice. This would explain the furin site not seen in other sarbecoviruses and why humans topped the list for binding affinity from the outset.
Note the cases near the market are based on what David Relman described as "hopelessly impoverished" early case data. There was also sampling bias in retrospectively counting cases as market link was often required. WHO hasn't accepted market origin in part as there were likely much earlier cases than those in December linked to the market where no animals tested positive.
You can't read much into the early case data that David Relman described as "hopelessly impoverished". There were likely much earlier cases based on excess mortality data (a key reason WHO haven't accepted market origin). Also, there is a clear sampling bias in the cases in the article cited above. https://journals.asm.org/doi/10.1128/mbio.00313-23